pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Arsenal Biosciences cuts ‘majority’ of staff in move to in vivo CAR-T

Roughly a year after shedding half of its workforce, Arsenal Biosciences is trimming its headcount again by letting go of “the majority” of its staffers as a result of a pivot into in vivo CAR-T ...

Sep 1, 2026·read at Endpoints ↗

September 1, 2026 01:12 PM EDT PeoplePharma Ar­se­nal Bio­sciences cuts ‘ma­jor­i­ty’ of staff in move to in vi­vo CAR-T Anna Brown News Reporter Rough­ly a year af­ter shed­ding half of its work­force, Ar­se­nal Bio­sciences is trim­ming its head­count again by let­ting go of “the ma­jor­i­ty” of its staffers … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
83 words · retrieved 30m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Arsenal Biosciences Inc2
topics
CAR-T3

related stories

  • 6h agoArsenalBio sacrifices ‘majority’ of staff in pivot to in vivo CAR TBioSpace
  • 9h agoArsenalBio sheds most of staff in pivot to in vivo CAR-TFierce Biotech
  • Jun 1#ASCO26: Kelonia Therapeutics delivers an impressive in vivo CAR-T updateEndpoints
  • May 28#ASCO26: After leaving Legend, Frank Fan is ready to showcase his next projectEndpoints
  • May 20STAT+: 23andMe offers to connect users’ DNA data with medical recordsSTAT